Home

Emerging Companies

Podcast: David Malek, Vice President of Business Development for BioLine Rx
Recent Approvals; M&A Activity Create Early Buzz for 14th Annual BIO CEO & Investor Conference

BIO CEO & Investor Conference will be held February 13-14 in New York City.

Jane Hollingsworth, co-founder, director and CEO of NuPathe Inc.

NuPathe will be presenting at the upcoming BIO CEO & Investor Conference

Tracey Mumford, The Michael J. Fox Foundation for Parkinson’s Research

The Michael J. Fox Foundation for Parkinson's Research will be presenting at the 14th Annual BIO CEO & Investor Conference in New York on February 13-14, 2012

New Orleans Biotech Center Drives Job Growth and Diversifies Economy

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The city reached a  milestone its renaissance when the New Orleans BioInnovation Center (NOBIC) opened for business.

BIO One-on-One Partnering

The biotechnology and pharmaceutical industries are continuously trying to improve efficiency in access to industry knowledge, innovation, and therapies.

Capital Formation Spurs Job Growth

Congress has the opportunity to help speed lifesaving cures and treatments to patients by removing burdens to innovation in our industry.

How to Grow Jobs Through Biotech Industry Development

Jobs and salaries in this industry have substantially grown in the past ten years. To date, there are more than 47,000 bioscience companies and 1.4 million workers in the United States.

Top 5 Reasons Why SBIR Must be Reauthorized Now

The Small Business Innovation Research Grants Program Provides Critical Support to Small Biotech Companies Working on Promising Innovations

The Power of Partnering, Expanded

Where can you network and partner with 15,000+ industry leaders from 65 countries across the globe?

Discovery to Step Out of the Shadows at BIO Investor Forum

There are many reasons to be excited about financing early stage biotech companies. The BIO Investor Forum will assemble the most promising among promising discovery stage companies. 

How States Can Foster and Expand Biotech Industry Development

In this global economy, nearly every competitor has access to big breakthroughs in technology and to the equipment and capital to produce standardized products, but those regions that possess the human capital, with its insights, competencies, and experience will have the competitive advantage.

Becoming a Part of the Biotech Industry

Pete Pellerito discusses what is being done to provide the workforce for this broad and growing industry.

Podcast: Margaret Anderson, Executive Director of FasterCures

FasterCuresis a nonpartisan organization that works to improve the medical research system to speed up the time it takes to get important new medicines from discovery to patients.

Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech

Jack discusses her greatest accomplishments, advice for industry leaders, and the promise of biotech. Pulmatrix is a clinical trial stage biotech company based in Lexington, Mass.

Letters, Testimony & Comments

The 10th Anniversary of the Sarbanes-Oxley Act, Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals On behalf of the Biotechnology Industry...
BIO Supports the JOBS Act (H.R. 3606)
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell: On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
Spurring Job Growth Through Capital Formation While Protecting Investors
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
BIO Written Testimony: Spurring Job Growth Through Capital Formation While Protecting Investors
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
Driving Innovation and Job Growth Through the Life Sciences Industry
May 25 2011
Good morning Chairman Casey, Vice Chairman Brady, Ranking Member DeMint, Ranking Member Hinchey, Members of the Committee, ladies, and...
More Letters, Testimony & Comments →

Press Releases

BIO Praises SBA for Publishing Final Rule on SBIR/STTR Reauthorization
January 8 2013
WASHINGTON DC, January 8, 2013 -- BIO lauds the Administration and the U.S. Small Business Association (SBA) for...
BIO Praises Introduction of the High Technology Small Business Research Incentives Act
September 25 2012
Washington, D.C. (September 25, 2012) – The Biotechnology Industry Organization (BIO) applauds Sens. Robert...
Biotech Leader Provides Testimony at Congressional Hearing on Sarbanes-Oxley
July 26 2012
Washington, D.C. (July 26, 2012) – Today, the House Subcommittee on Capital Markets held a hearing entitled...
BIO Praises Rep. Michael Fitzpatrick on Introduction of Fostering Innovation Act
July 20 2012
Washington, D.C. (July 20, 2012) – Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the...
Scientific American to Host BIO International Convention Super Session to Release 4th Annual Worldview Report and Scorecard Highlighting Emerging Markets
June 6 2012
Washington, DC and New York, NY, Wednesday, June 6, 2012 -The 4th Annual Scientific American Worldview Report and...
More Press Releases →